This compound is a cyclic peptide somatostatin analog used as an active pharmaceutical ingredient. Its structure features multiple amide bonds, aromatic rings, and a disulfide bridge, indicating high polarity and complexity typical of peptide-based drug substances.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing San 201-456?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Octreotide Impurity 38
research compound
(Cysteinol7,des-L-threoninol8)-Octreotide acetate salt
pharmaceutical raw material
Octreotide Impurity 13
pharmaceutical raw material
O-Acetyl Octreotide
pharmaceutical raw material
Levocabastine
pharmaceutical raw material
Octreotide acetate
pharmaceutical raw material
Sertraline hydrochloride
pharmaceutical raw material
Alarelin
pharmaceutical raw material
(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
PWRIWNRQEPOGNP-DYDSHOKNSA-N
C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@H](CC5=CC=CC=C5)N)C(=O)N)O
Sourcing San 201-456?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.